A Pathogenetic Classification of Diabetic Macular Edema

Area of Science:

• Ophthalmology
• Retinal Diseases
• Medical Imaging

Background:

• Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
• Current classifications may not fully capture the diverse pathogenetic mechanisms of DME.
• Accurate classification is crucial for effective treatment strategies.

Purpose of the Study:

• To define a novel pathogenetic classification for diabetic macular edema (DME).
• To evaluate the application of this new classification in clinical practice.
• To identify distinct DME subtypes based on specific clinical and OCT findings.

Main Methods:

• Prospective enrollment of 177 patients with center-involving DME and central retinal thickness (CRT) ≥250 µm.
• Comprehensive ophthalmological examination including BCVA, fundus photography, and spectral-domain OCT.
• Classification based on retinal thickening, vascular dilation, and macular traction, with analysis of OCT parameters like CRT, subretinal fluid, intraretinal cysts, and hyper-reflective foci (HF).

Main Results:

• Four DME subtypes identified: vasogenic (131 eyes), nonvasogenic (46 eyes), tractional (11 eyes), and mixed (13 eyes).
• Vasogenic DME was prevalent across all CRT levels; tractional DME was more common with CRT > 400 µm.
• Internal/external cysts and hard exudates were characteristic of vasogenic DME; HF were evenly distributed.

Conclusions:

• A new pathogenetic classification for DME effectively differentiates between subtypes.
• This classification highlights significant variations among DME subtypes.
• Tailored therapeutic approaches can be developed based on these distinct DME subtypes.